Xi'an, China

Ning Zhao

This inventor holds 1 USPTO granted patent. Top assignee: The Fourth Military Medical University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ning Zhao. Retrieved from https://idiyas.com/inventor/ning-zhao-2ss79cw9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ning Zhao: Innovator in Monoclonal Antibody Research

Introduction

Ning Zhao is a prominent inventor based in Xi'an, China. He has made significant contributions to the field of medical research, particularly in the development of monoclonal antibodies. His work is vital for advancing therapeutic options in various medical conditions.

Latest Patents

Ning Zhao holds a patent for an "ANTI-GDF15 NEUTRALIZING MONOCLONAL ANTIBODY AND USE THEREOF." This innovative patent showcases his expertise in creating targeted therapies that can potentially improve patient outcomes.

Career Highlights

Ning Zhao is affiliated with The Fourth Military Medical University, where he conducts research and develops new medical technologies. His dedication to advancing medical science is evident in his innovative approaches and research methodologies.

Collaborations

Ning Zhao collaborates with talented colleagues, including Yingqi Zhang and Meng Li. Their combined efforts contribute to the success of their research projects and the advancement of medical knowledge.

Conclusion

Ning Zhao's work in monoclonal antibody research exemplifies the impact of innovation in medicine. His contributions are paving the way for new therapeutic solutions that can benefit many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…